Table 1. Demographics of study participants administered test and reference formulations of 100 mg tegoprazan tablets.
| Variable | Total (n = 12) | Sequence A (Reference → Test, n = 6) | Sequence B (Test → Reference, n = 6) | P-value1) |
|---|---|---|---|---|
| Age (years) | 23.9 ± 1.3 (22.0–27.0) | 24.2 ± 1.6 (22.0–27.0) | 23.7 ± 1.0 (22.0–25.0) | 0.73 |
| Height (cm) | 173.1 ± 7.6 (162.1–184.6) | 174.2 ± 8.2 (165.0–184.0) | 172.0 ± 7.6 (162.1–184.6) | 0.64 |
| Weight (kg) | 68.4 ± 8.2 (55.2–80.7) | 68.7 ± 9.6 (55.2–80.7) | 68.0 ± 7.5 (56.9–75.1) | 0.98 |
| BMI (kg/m2) | 22.8 ± 2.2 (19.3–26.0) | 22.5 ± 2.2 (19.9–26.0) | 23.0 ± 2.5 (19.3–25.6) | 0.75 |
1)Independent t-test.